{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:38Z","timestamp":1787028398108,"version":"build-2736575974"},"reference-count":67,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IRCCS Istituto Ortopedico Galeazzi","award":["L4080"],"award-info":[{"award-number":["L4080"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parathyroid cancers (PCas) are rare malignancies representing approximately 0.005% of all cancers. PCas are a rare cause of primary hyperparathyroidism, which is the third most common endocrine disease, mainly related to parathyroid benign tumors. About 90% of PCas are hormonally active hypersecreting parathormone (PTH); consequently patients present with complications of severe hypercalcemia. Pre-operative diagnosis is often difficult due to clinical features shared with benign parathyroid lesions. Surgery provides the current best chance of cure, though persistent or recurrent disease occurs in about 50% of patients with PCas. Somatic inactivating mutations of CDC73\/HRPT2 gene, encoding parafibromin, are the most frequent genetic anomalies occurring in PCas. Recently, the aberrant DNA methylation signature and microRNA expression profile have been identified in PCas, providing evidence that parathyroid malignancies are distinct entities from parathyroid benign lesions, showing an epigenetic signature resembling some embryonic aspects. The present paper reviews data about epigenetic alterations in PCas, up to now limited to DNA methylation, chromatin regulators and microRNA profile.<\/jats:p>","DOI":"10.3390\/ijms18020310","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T10:53:53Z","timestamp":1485946433000},"page":"310","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Epigenetic Alterations in Parathyroid Cancers"],"prefix":"10.3390","volume":"18","author":[{"given":"Chiara","family":"Verdelli","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Endocrinology, IRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8140-3175","authenticated-orcid":false,"given":"Sabrina","family":"Corbetta","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Department of Biomedical Sciences for Health, University of Milan, IRCCS Istituto Ortopedico Galeazzi, 20097 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ando.2015.03.015","article-title":"Epidemiology, pathogenesis of primary hyperparathyroidism: Current data","volume":"76","author":"Marcocci","year":"2015","journal-title":"Ann. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MOO.0000000000000234","article-title":"Parathyroid carcinoma","volume":"24","author":"Goswamy","year":"2016","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-016-5248-6","article-title":"Differentiating atypical parathyroid neoplasm from parathyroid cancer","volume":"23","author":"Christakis","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: Update and guidelines for management","volume":"13","author":"Wei","year":"2012","journal-title":"Curr. Treat. Opt. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4158\/EP14410.OR","article-title":"The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia","volume":"21","author":"Fountas","year":"2015","journal-title":"Endocr. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-4608(98)00049-1","article-title":"Comparative genomic hybridization analysis of human parathyroid tumors","volume":"106","author":"Agarwal","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9440(10)64568-3","article-title":"Patterns of chromosomal imbalances in parathyroid carcinomas","volume":"157","author":"Farnebo","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinase associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J. Clin. Endocirnol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/j.seminoncol.2010.10.013","article-title":"Parathyroid cancer","volume":"37","author":"Sharretts","year":"2010","journal-title":"Semin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr. Connect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","article-title":"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas","volume":"67","author":"Haven","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_14","first-page":"103","article-title":"Absence of p53 point mutations in parathyroid adenoma and carcinoma","volume":"78","author":"Hakim","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","first-page":"1320","article-title":"p53 abnormalities in human parathyroid carcinoma","volume":"78","author":"Cryns","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2265.2003.01814.x","article-title":"Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma","volume":"59","author":"Shattuck","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., and Wang, J. (2015). Integrative analysis of 111 reference human epigenomes. Nature, 518, 317\u2013330.","DOI":"10.1038\/nature14248"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1158\/0008-5472.CAN-12-3658","article-title":"A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task Force","volume":"72","author":"Beck","year":"2012","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 45, 1113\u20131120.","DOI":"10.1038\/ng.2764"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/gcc.20895","article-title":"The DNA methylome of benign and malignant parathyroid tumors","volume":"50","author":"Starker","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/epi.24823","article-title":"Global and gene-specific promoter methylation analysis in primary hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gnh032","article-title":"A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements","volume":"32","author":"Yang","year":"2004","journal-title":"Nucleic Acid. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13148-016-0197-2","article-title":"5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma","volume":"8","author":"Barazeghi","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1476-4598-9-294","article-title":"Aberrant WNT\/\u03b2-catenin signaling in parathyroid carcinoma","volume":"9","author":"Svedlund","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1158\/0008-5472.CAN-04-4088","article-title":"Role of the Ras-association domain family 1 tumor suppressor gene in human cancers","volume":"65","author":"Agathanggelou","year":"2005","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.1210\/jc.2011-3136","article-title":"Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification","volume":"97","author":"Svedlund","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sulaiman, L., Haglund, F., Hashemi, J., Obara, T., Nordenstr\u00f6m, J., Larsson, C., and Juhlin, C.C. (2012). Genome-wide and locus specific alterations in CDC73\/HRPT2-mutated parathyroid tumors. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046325"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/ERC-09-0291","article-title":"CDC73\/HRPT2 CpG island hypermethylation and mutation of 5\u2019-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors","volume":"17","author":"Hahn","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000348940711601210","article-title":"Aberrant methylation of the HRPT2 gene in parathyroid carcinoma","volume":"116","author":"Hewitt","year":"2007","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","article-title":"Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia","volume":"52","author":"Corbetta","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.0.1480403","article-title":"Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas","volume":"148","author":"Yano","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/JME-11-0189","article-title":"The microRNA cluster C19MC is deregulated in parathyroid tumours","volume":"49","author":"Vaira","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cncr.25482","article-title":"The role of epigenetic transcription repression and DNA methyltransferases in cancer","volume":"117","author":"Daniel","year":"2011","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with \u03b2-catenin\/Armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/joim.12458","article-title":"Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours","volume":"280","author":"Westin","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/ERC-09-0147","article-title":"\u03b2-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas","volume":"17","author":"Cetani","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mc.20591","article-title":"The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA","volume":"49","author":"Farber","year":"2010","journal-title":"Mol. Carcinog."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","article-title":"Gene expression of parathyroid tumors: Molecular subclassification and identification of the potential malignant phenotype","volume":"64","author":"Haven","year":"2004","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/hmg\/ddr490","article-title":"The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination","volume":"21","author":"Hahn","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/ERC-13-0497","article-title":"The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors","volume":"21","author":"Svedlund","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12020-016-0892-y","article-title":"EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms","volume":"54","author":"Sanpaolo","year":"2016","journal-title":"Endocrine"},{"key":"ref_44","first-page":"175","article-title":"Diverse involvement of EZH2 in cancer epigenetics","volume":"7","author":"Dupret","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25679","article-title":"Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis","volume":"56","author":"Au","year":"2012","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","article-title":"The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression","volume":"38","author":"Yang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nm.4092","article-title":"An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation","volume":"22","author":"Souroullas","year":"2016","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"microRNAs in cancer","volume":"9","author":"Garofalo","year":"2014","journal-title":"Ann. Rev. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/ERC-09-0134","article-title":"Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1245\/s10434-010-1359-7","article-title":"Identification of differentially expressed microRNA in parathyroid tumors","volume":"18","author":"Rahbari","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"25","author":"Hughes","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2011.354","article-title":"DNA methylation-associated sllencing of tumor-suppressor microRNAs- in cancer","volume":"31","author":"Esteller","year":"2012","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1093\/nar\/gkp205","article-title":"C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts","volume":"37","author":"Dance","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.compbiolchem.2010.08.001","article-title":"Computational identification and characterization of primate-specific microRNAs in human genome","volume":"34","author":"Lin","year":"2010","journal-title":"Comput. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.placenta.2012.05.009","article-title":"MicroRNA expression profiles of trophoblastic cells","volume":"33","author":"Chaiwangyen","year":"2012","journal-title":"Placenta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4161\/epi.4.8.10230","article-title":"Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells","volume":"4","author":"Tsai","year":"2009","journal-title":"Epigenetics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e88856","DOI":"10.1172\/jci.insight.88856","article-title":"Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma","volume":"1","author":"Strub","year":"2016","journal-title":"JCI Insight"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Barnes, D.J., Hookway, E., Athanasou, N., Kashima, T., Oppermann, U., Hughes, S., Swan, D., Lueerssen, D., Anson, J., and Hassan, A.B. (2016). A germline mutation of CDKN2A and a novel RPLP1-C19MC fusion detected in a rare melanotic neuroectoderma tumor of infancy: A case report. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2669-3"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ng.2849","article-title":"Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR","volume":"46","author":"Kleinman","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_60","first-page":"281","article-title":"Expression of microRNAs of C19MC in different histological types of testicular germ cell tumour","volume":"13","author":"Flor","year":"2016","journal-title":"Cancer Genomics Proteomics"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1080\/15548627.2015.1108507","article-title":"MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation","volume":"11","author":"Lu","year":"2015","journal-title":"Autophagy"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2350\/15-01-1600-OA.1","article-title":"Methylation status of the chromosome arm 19q MicroRNA cluster in sporadic and androgenetic-biparental mosaicism-associated hepatic mesenchymal hamartoma","volume":"18","author":"Keller","year":"2015","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Vaira, V., Verdelli, C., Forno, I., and Corbetta, S. (2016). MicroRNAs in parathyroid physiopathology. Mol. Cell. Endocrinol.","DOI":"10.1016\/j.mce.2016.10.035"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/stem.2378","article-title":"A miR-372\/let-7 axis regulates human germ versus somatic cell fates","volume":"34","author":"Tran","year":"2016","journal-title":"Stem Cells"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1261\/rna.029561.111","article-title":"MicroRNAs 296 and 298 are imprinted and part of the GNAS\/Gnas cluster and miR-296 targets IKBKE and Tmed9","volume":"18","author":"Robson","year":"2012","journal-title":"RNA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20130580","article-title":"miR-296\/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo","volume":"127","author":"Savi","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/0008-5472.CAN-12-4232","article-title":"Regulation of lung cancer metastasis by Klf4-Numb-like signaling","volume":"73","author":"Vaira","year":"2013","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/2\/310\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:27:21Z","timestamp":1760207241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/2\/310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"alternative-id":["ijms18020310"],"URL":"https:\/\/doi.org\/10.3390\/ijms18020310","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}